Cargando…
Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients
BACKGROUND: The risk of adverse pregnancy outcomes is increased by having a polycystic ovary syndrome (PCOS) diagnosis. However, the confounders in previous studies preclude firm conclusions, and further studies are warranted. OBJECTIVES: To investigate whether PCOS affects pregnancy outcomes and co...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546360/ https://www.ncbi.nlm.nih.gov/pubmed/33101210 http://dx.doi.org/10.3389/fendo.2020.575337 |
_version_ | 1783592214865117184 |
---|---|
author | Liu, Su Mo, Meilan Xiao, Shan Li, Longfei Hu, Xiuyu Hong, Ling Wang, Linlin Lian, Ruochun Huang, Chunyu Zeng, Yong Diao, Lianghui |
author_facet | Liu, Su Mo, Meilan Xiao, Shan Li, Longfei Hu, Xiuyu Hong, Ling Wang, Linlin Lian, Ruochun Huang, Chunyu Zeng, Yong Diao, Lianghui |
author_sort | Liu, Su |
collection | PubMed |
description | BACKGROUND: The risk of adverse pregnancy outcomes is increased by having a polycystic ovary syndrome (PCOS) diagnosis. However, the confounders in previous studies preclude firm conclusions, and further studies are warranted. OBJECTIVES: To investigate whether PCOS affects pregnancy outcomes and complications in infertile women undergoing their first in vitro fertilization (IVF) treatment, taking into account important confounders. METHODS: We performed a retrospective cohort study of 7,678 infertile women, including 666 women with PCOS and 7,012 controls undergoing their first IVF treatment at a private fertility center from January 2010 to December 2017. Our main outcome was the impact of PCOS on adverse pregnancy outcomes (miscarriage, preterm delivery, pregnancy-induced hypertension) and pregnancy outcomes (live birth rate, clinical pregnancy rate, implantation rate). PCOS effects were summarized by adjusted odds ratios (aORs) with 95% confidence intervals (CIs) after controlling for maternal characteristics. RESULTS: After adjusting for differences in maternal age, BMI, infertility duration, total dose of gonadotropin, serum E(2) and endometrial thickness on the day of hCG trigger, number of fertilized occytes, number of embryos transferred, embryo type (cleavage-stage embryo or blastocyst) and quality, women with PCOS had an increased risk of developing unfavorable pregnancy complications, including miscarriage (aOR 1.629, 95% CI 1.240–2.141), very preterm delivery (< 32 weeks) (aOR 2.072, 95% CI 1.133–3.791). For pregnancy outcomes, PCOS was associated with higher clinical pregnancy rate (aOR 1.248, 95% CI 1.038–1.501) and implantation rate (aOR 1.238, 95% CI 1.030–1.489) after adjusting for the above-mentioned confounders. CONCLUSIONS: Women with PCOS are at increased risk of adverse pregnancy outcomes after adjusting for differences in maternal characteristics. These women may need more frequent medical consultants and management during pregnancy and parturition. |
format | Online Article Text |
id | pubmed-7546360 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75463602020-10-22 Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients Liu, Su Mo, Meilan Xiao, Shan Li, Longfei Hu, Xiuyu Hong, Ling Wang, Linlin Lian, Ruochun Huang, Chunyu Zeng, Yong Diao, Lianghui Front Endocrinol (Lausanne) Endocrinology BACKGROUND: The risk of adverse pregnancy outcomes is increased by having a polycystic ovary syndrome (PCOS) diagnosis. However, the confounders in previous studies preclude firm conclusions, and further studies are warranted. OBJECTIVES: To investigate whether PCOS affects pregnancy outcomes and complications in infertile women undergoing their first in vitro fertilization (IVF) treatment, taking into account important confounders. METHODS: We performed a retrospective cohort study of 7,678 infertile women, including 666 women with PCOS and 7,012 controls undergoing their first IVF treatment at a private fertility center from January 2010 to December 2017. Our main outcome was the impact of PCOS on adverse pregnancy outcomes (miscarriage, preterm delivery, pregnancy-induced hypertension) and pregnancy outcomes (live birth rate, clinical pregnancy rate, implantation rate). PCOS effects were summarized by adjusted odds ratios (aORs) with 95% confidence intervals (CIs) after controlling for maternal characteristics. RESULTS: After adjusting for differences in maternal age, BMI, infertility duration, total dose of gonadotropin, serum E(2) and endometrial thickness on the day of hCG trigger, number of fertilized occytes, number of embryos transferred, embryo type (cleavage-stage embryo or blastocyst) and quality, women with PCOS had an increased risk of developing unfavorable pregnancy complications, including miscarriage (aOR 1.629, 95% CI 1.240–2.141), very preterm delivery (< 32 weeks) (aOR 2.072, 95% CI 1.133–3.791). For pregnancy outcomes, PCOS was associated with higher clinical pregnancy rate (aOR 1.248, 95% CI 1.038–1.501) and implantation rate (aOR 1.238, 95% CI 1.030–1.489) after adjusting for the above-mentioned confounders. CONCLUSIONS: Women with PCOS are at increased risk of adverse pregnancy outcomes after adjusting for differences in maternal characteristics. These women may need more frequent medical consultants and management during pregnancy and parturition. Frontiers Media S.A. 2020-09-25 /pmc/articles/PMC7546360/ /pubmed/33101210 http://dx.doi.org/10.3389/fendo.2020.575337 Text en Copyright © 2020 Liu, Mo, Xiao, Li, Hu, Hong, Wang, Lian, Huang, Zeng and Diao http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Liu, Su Mo, Meilan Xiao, Shan Li, Longfei Hu, Xiuyu Hong, Ling Wang, Linlin Lian, Ruochun Huang, Chunyu Zeng, Yong Diao, Lianghui Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients |
title | Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients |
title_full | Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients |
title_fullStr | Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients |
title_full_unstemmed | Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients |
title_short | Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients |
title_sort | pregnancy outcomes of women with polycystic ovary syndrome for the first in vitro fertilization treatment: a retrospective cohort study with 7678 patients |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546360/ https://www.ncbi.nlm.nih.gov/pubmed/33101210 http://dx.doi.org/10.3389/fendo.2020.575337 |
work_keys_str_mv | AT liusu pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients AT momeilan pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients AT xiaoshan pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients AT lilongfei pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients AT huxiuyu pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients AT hongling pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients AT wanglinlin pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients AT lianruochun pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients AT huangchunyu pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients AT zengyong pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients AT diaolianghui pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients |